Breast disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Those who voluntarily participate in the trial and sign the written informed consent; 2)Female patients with primary breast cancer without severe underlying diseases such as heart, lung, brain, etc., and without distant metastases such as bone, lung, and liver; 3) Those who have undergone mastectomy and have not reached the indication of removing the drainage tube for 14 days after the operation.
Exclusion criteria
Exclusion criteria: 1) Women during pregnancy or breastfeeding; 2) Patients with immediate breast reconstruction after surgery; 3) Those who have severe uncontrolled medical diseases or acute infections prior to surgery; 4) Those who develop postoperative infection in the incision area; 5) Those with multiple drug allergies; 6) Other conditions that the investigator considers inappropriate for enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cumulative indwelling time of drainage tubes;Daily Drainage Fluid Volume and Total Drainage Fluid Volume;Incidence of seroma after extubation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative complications (short-term safety);Local recurrence rate, distant metastasis rate, and mortality rate within 5 years after surgery (long-term safety);Postoperative quality of life (quality of life score);Number of postoperative medication dressing changes, dressing change costs and related transportation costs (economics); | — |
Countries
China
Contacts
West China hospital, Sichuan University